Nestlé plans to acquire nutritional health product maker Atrium Innovations Inc. for $2.3 billion. Plans call for Montreal-based Atrium, which is being purchased from a group of investors led by Permira Funds, to become part of Nestlé Health Science, Nestlé said Tuesday.
IRI has allied with Time Inc. subsidiary Viant to provide “people-based” target marketing and measurement for consumer packaged goods (CPG) and retail marketers.
Moberg Pharma AB is sharpening its focus on the North American marketplace as part of a reorganization of its sales and marketing operations. Moberg said it’s forming a global consumer health sales and marketing unit that includes both direct and distributor sales.
After a priority review of its supplemental Biologics License Application, Amgen has gained approval from the Food and Drug Administration for the cardiovascular drug Repatha.
Mylan N.V. has received Food and Drug Administration approval for Ogivri (trastuzumab-dkst), a biosimilar oncology drug co-developed with Biocon Ltd.
In January, Gillette plans to roll out eight men’s and women’s shaving and grooming solutions that the brand calls its “most comprehensive innovation bundle ever.
Lannett Co. has entered into an agreement with Aralez Pharmaceuticals Trading DAC, an Irish designated activity company, to become the exclusive U.S. distributor for metoprolol succinate extended-release tablets, a cardiovascular medication. Financial terms weren’t disclosed.
International cosmetics brand IsaDora has launched its line of beauty products in the United States on Walgreens.com. IsaDora, Sweden’s No. 1 beauty brand, has seen steady growth in the global cosmetic market.
Unilever has announced an agreement to acquire Sundial Brands, a leading haircare and skincare company recognized for its innovative use of high-quality and culturally authentic ingredients. Sundial’s brands include SheaMoisture, Nubian Heritage, Madam C.J. Walker and nyakio.
Just over two months after naming a new chief executive officer, Teva Pharmaceutical Industries Ltd., the world’s largest maker of generic drugs, is reorganizing its business and leadership structure.
Just in time for winter skin care routines, Vaseline has introduced Vaseline Intensive Care Cocoa Radiant Smoothing Body Butter.
Teva Pharmaceuticals USA has launched a U.S. prescription co-payment assistance program in the U.S. for its imatinib mesylate tablets, a cancer treatment.
Foundation Consumer Healthcare (FCH) has named Greg Bradley president and chief executive officer. The move comes as Foundation Consumer Healthcare has completed its $675 million acquisition of Plan B One-Step and two value emergency contraceptive brands from Teva Pharmaceutical Industries Ltd.
AmerisourceBergen Corp. plans to acquire fellow pharmaceutical distributor H.D. Smith for $815 million in cash. The companies said late Monday that the transaction, pending regulatory review and other closing conditions, is expected to close in early 2018. Springfield, Ill.-based H. D.
PharmaSmart International Inc. welcomed new guidelines updating the definition of hypertension and stressing the use of validated devices for measuring blood pressure.
Next year, Kaleo plans to release Auvi-Q 0.1 mg, a version of its epinephrine auto-injector for infants and small children. Kaleo said Monday that the Food and Drug Administration has approved its supplemental New Drug Application (sNDA) for Auvi-Q 0.
